Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Endocrine neoplasms in familial syndromes of hyperparathyroidism
Yulong Li
, William F. Simonds
Division of Endocrinology, Metabolism & Lipid Research
Research output
:
Contribution to journal
›
Article
›
peer-review
32
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Endocrine neoplasms in familial syndromes of hyperparathyroidism'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Endocrine Neoplasm
100%
Hyperparathyroidism
100%
Familial Syndromes
100%
Tumor
50%
Multiple Endocrine Neoplasia Type 2 (MEN2)
50%
Multiple Endocrine Neoplasia Type 1 (MEN1)
50%
Familial Hyperparathyroidism
50%
Disease Pattern
25%
Molecular Pathogenesis
25%
Medical Therapy
25%
Neoplasms
25%
Neoplasia
25%
New Drugs
25%
Expert Opinion
25%
Natural History
25%
Radiological Assessment
25%
Pheochromocytoma
25%
Neuroendocrine Tumor
25%
Biochemical Assessment
25%
Surgical Therapy
25%
Hyperparathyroidism-jaw Tumor Syndrome (HPT-JT)
25%
Technological Progress
25%
Malignant Potential
25%
Primary Hyperparathyroidism (pHPT)
25%
Natural Management
25%
Parathyroid Carcinoma
25%
Different Characteristics
25%
Large-scale Clinical Trial
25%
Medullary Thyroid Cancer
25%
Enteropancreatic
25%
Familial Tumors
25%
Jaw Tumors
25%
Potential Malignancy
25%
Medicine and Dentistry
Neoplasm
100%
Hyperparathyroidism
100%
Primary Hyperparathyroidism
60%
Tumor
40%
Jaw Tumor
40%
Multiple Endocrine Neoplasia Type I
40%
Multiple Endocrine Neoplasia Type 2a
40%
Diseases
40%
Clinical Trial
20%
Cancer
20%
Molecular Pathology
20%
Combination Therapy
20%
Thyroid Cancer
20%
Cancer Syndrome
20%
Pheochromocytoma
20%
Neuroendocrine Tumor
20%
Familial Cancer
20%
Parathyroid Carcinoma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Syndrome
100%
Hyperparathyroidism
100%
Primary Hyperparathyroidism
42%
Multiple Endocrine Neoplasia Type 1
28%
Multiple Endocrine Neoplasia Type 2a
28%
Jaw Tumor
28%
Diseases
28%
Combination Therapy
14%
Clinical Trial
14%
Thyroid Cancer
14%
Molecular Pathology
14%
Pheochromocytoma
14%
Neuroendocrine Tumor
14%
Tumor Syndrome
14%
Parathyroid Carcinoma
14%
Hereditary Tumor Syndrome
14%